LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001 - Revision history

Editor: LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001:01 moved to LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001

2010-04-14T21:00:00Z

LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001:01 moved to LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001

← Older revision		Revision as of 06:00, 15 April 2010
Line 4:		Line 4:
	\|LipidBank=PPA0020		\|LipidBank=PPA0020
	\|SysName=1-O-Octadecyl-2-O-acetyl-sn-glyceryl-3-phosphocholine		\|SysName=1-O-Octadecyl-2-O-acetyl-sn-glyceryl-3-phosphocholine
	\|Common Name=&&Platelet Activating Factor~~&&1-O-Octadecyl-2-O-acetyl-sn-glyceryl-3-phosphocholine~~&&		\|Common Name=&&Platelet Activating Factor&&
	\|Melting Point=260° <<0015>>		\|Melting Point=260° <<0015>>
	\|Reflactive=[ alpha ]_D = -0.48° (c=5, CHCl3/CH3OH 1/1) <<0015>>		\|Reflactive=[ alpha ]_D = -0.48° (c=5, CHCl3/CH3OH 1/1) <<0015>>

Editor: LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001:01 moved to LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001

2010-02-25T10:00:10Z

LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001:01 moved to LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001

← Older revision		Revision as of 19:00, 25 February 2010
(No difference)

Editor: LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001:01 moved to LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001

2010-02-19T14:00:10Z

LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001:01 moved to LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001

← Older revision		Revision as of 23:00, 19 February 2010
Line 6:		Line 6:
	\|Common Name=&&Platelet Activating Factor&&1-O-Octadecyl-2-O-acetyl-sn-glyceryl-3-phosphocholine&&		\|Common Name=&&Platelet Activating Factor&&1-O-Octadecyl-2-O-acetyl-sn-glyceryl-3-phosphocholine&&
	\|Melting Point=260° <<0015>>		\|Melting Point=260° <<0015>>
	\|Reflactive=[alpha]_D = -0.48° (c=5, CHCl3/CH3OH 1/1) <<0015>>		\|Reflactive=[ alpha ]_D = -0.48° (c=5, CHCl3/CH3OH 1/1) <<0015>>
	\|IR Spectra=3460 (H2O); 1746 (Ester-Carbonyl); 1256 (Ester and P=O); 1100 (Ether); 1069(P-O). <<0015>>		\|IR Spectra=3460 (H2O); 1746 (Ester-Carbonyl); 1256 (Ester and P=O); 1100 (Ether); 1069(P-O). <<0015>>
	\|NMR Spectra=^1 H-NMR (80 MHz): 0.9(t, 3H, (CH2)16CH3); 1.30(br. s, ca.32H, (CH2)l6CH3); 2.06 (s, 3H, COCH3); 3.35(s, ca. 9H, N(CH3)3); ca. 3.4.-4.50 (m, ca. l0H, 4-OCH2 and CH2-N(CH3)3); 5.10(m, lH, H-C(2) <<0015>>,		\|NMR Spectra=^1 H-NMR (80 MHz): 0.9(t, 3H, (CH2)16CH3); 1.30(br. s, ca.32H, (CH2)l6CH3); 2.06 (s, 3H, COCH3); 3.35(s, ca. 9H, N(CH3)3); ca. 3.4.-4.50 (m, ca. l0H, 4-OCH2 and CH2-N(CH3)3); 5.10(m, lH, H-C(2) <<0015>>,

Editor: LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001:01 moved to LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001

2010-02-19T14:00:00Z

LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001:01 moved to LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001

← Older revision		Revision as of 23:00, 19 February 2010
Line 6:		Line 6:
	\|Common Name=&&Platelet Activating Factor&&1-O-Octadecyl-2-O-acetyl-sn-glyceryl-3-phosphocholine&&		\|Common Name=&&Platelet Activating Factor&&1-O-Octadecyl-2-O-acetyl-sn-glyceryl-3-phosphocholine&&
	\|Melting Point=260° <<0015>>		\|Melting Point=260° <<0015>>
	\|Reflactive=[~~<FONT FACE="Symbol">a</FONT>~~]~~<SUB><FONT SIZE=-1>D</FONT></SUB>~~= -0.48° (c=5, CHCl3/CH3OH 1/1) <<0015>>		\|Reflactive=[alpha]_D = -0.48° (c=5, CHCl3/CH3OH 1/1) <<0015>>
	\|IR Spectra=3460 (H2O); 1746 (Ester-Carbonyl); 1256 (Ester and P=O); 1100 (Ether); 1069(P-O). <<0015>>		\|IR Spectra=3460 (H2O); 1746 (Ester-Carbonyl); 1256 (Ester and P=O); 1100 (Ether); 1069(P-O). <<0015>>
	\|NMR Spectra=~~<SUP><FONT SIZE=-~~1~~>1</FONT></SUP>~~H-NMR (80 MHz): 0.9(t, 3H, (CH2)16CH3); 1.30(br. s, ca.32H, (CH2)l6CH3); 2.06 (s, 3H, COCH3); 3.35(s, ca. 9H, N(CH3)3); ca. 3.4.-4.50 (m, ca. l0H, 4-OCH2 and CH2-N(CH3)3); 5.10(m, lH, H-C(2) <<0015>>,		\|NMR Spectra=^1 H-NMR (80 MHz): 0.9(t, 3H, (CH2)16CH3); 1.30(br. s, ca.32H, (CH2)l6CH3); 2.06 (s, 3H, COCH3); 3.35(s, ca. 9H, N(CH3)3); ca. 3.4.-4.50 (m, ca. l0H, 4-OCH2 and CH2-N(CH3)3); 5.10(m, lH, H-C(2) <<0015>>,
	}}		}}

	{{Lipid/Footer}}		{{Lipid/Footer}}

Editor: LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001:01 moved to LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001

2010-02-18T15:00:00Z

LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001:01 moved to LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001

← Older revision		Revision as of 00:00, 19 February 2010
Line 4:		Line 4:
	\|LipidBank=PPA0020		\|LipidBank=PPA0020
	\|SysName=1-O-Octadecyl-2-O-acetyl-sn-glyceryl-3-phosphocholine		\|SysName=1-O-Octadecyl-2-O-acetyl-sn-glyceryl-3-phosphocholine
	\|Common Name=Platelet Activating ~~Factor1~~-O-Octadecyl-2-O-acetyl-sn-glyceryl-3-phosphocholine		\|Common Name=&&Platelet Activating Factor&&1-O-Octadecyl-2-O-acetyl-sn-glyceryl-3-phosphocholine&&
	\|Melting Point=260° 0015		\|Melting Point=260° <<0015>>
	\|Reflactive=[FONT FACE=~~Symbola~~/FONT]~~SUBFONT~~ SIZE=-1D/FONT/SUB= -0.48° (c=5, CHCl3/CH3OH 1/1) 0015		\|Reflactive=[<FONT FACE="Symbol">a</FONT>]<SUB><FONT SIZE=-1>D</FONT></SUB>= -0.48° (c=5, CHCl3/CH3OH 1/1) <<0015>>
	\|IR Spectra=3460 (H2O); 1746 (Ester-Carbonyl); 1256 (Ester and P=O); 1100 (Ether); 1069(P-O). 0015		\|IR Spectra=3460 (H2O); 1746 (Ester-Carbonyl); 1256 (Ester and P=O); 1100 (Ether); 1069(P-O). <<0015>>
	\|NMR Spectra=~~SUPFONT~~ SIZE=-11/FONT/~~SUPH~~-NMR (80 MHz): 0.9(t, 3H, (CH2)16CH3); 1.30(br. s, ca.32H, (CH2)l6CH3); 2.06 (s, 3H, COCH3); 3.35(s, ca. 9H, N(CH3)3); ca. 3.4.-4.50 (m, ca. l0H, 4-OCH2 and CH2-N(CH3)3); 5.10(m, lH, H-C(2) 0015,		\|NMR Spectra=<SUP><FONT SIZE=-1>1</FONT></SUP>H-NMR (80 MHz): 0.9(t, 3H, (CH2)16CH3); 1.30(br. s, ca.32H, (CH2)l6CH3); 2.06 (s, 3H, COCH3); 3.35(s, ca. 9H, N(CH3)3); ca. 3.4.-4.50 (m, ca. l0H, 4-OCH2 and CH2-N(CH3)3); 5.10(m, lH, H-C(2) <<0015>>,
	}}		}}

	{{Lipid/Footer}}		{{Lipid/Footer}}

Editor: LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001:01 moved to LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001

2010-01-27T20:00:00Z

LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001:01 moved to LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001

← Older revision		Revision as of 05:00, 28 January 2010
Line 4:		Line 4:
	\|LipidBank=PPA0020		\|LipidBank=PPA0020
	\|SysName=1-O-Octadecyl-2-O-acetyl-sn-glyceryl-3-phosphocholine		\|SysName=1-O-Octadecyl-2-O-acetyl-sn-glyceryl-3-phosphocholine
	\|Common Name=&&Platelet Activating ~~Factor&&1~~-O-Octadecyl-2-O-acetyl-sn-glyceryl-3-phosphocholine&&		\|Common Name=Platelet Activating Factor1-O-Octadecyl-2-O-acetyl-sn-glyceryl-3-phosphocholine
	\|Melting Point=260° <<0015>>		\|Melting Point=260° 0015
	\|Reflactive=[<FONT FACE=~~"Symbol">a<~~/FONT>]~~<SUB><FONT~~ SIZE=-~~1>D<~~/FONT></SUB>= -0.48° (c=5, CHCl3/CH3OH 1/1) <<0015>>		\|Reflactive=[FONT FACE=Symbola/FONT]SUBFONT SIZE=-1D/FONT/SUB= -0.48° (c=5, CHCl3/CH3OH 1/1) 0015
	\|IR Spectra=3460 (H2O); 1746 (Ester-Carbonyl); 1256 (Ester and P=O); 1100 (Ether); 1069(P-O). <<0015>>		\|IR Spectra=3460 (H2O); 1746 (Ester-Carbonyl); 1256 (Ester and P=O); 1100 (Ether); 1069(P-O). 0015
	\|NMR Spectra=~~<SUP><FONT~~ SIZE=-~~1>1<~~/FONT></~~SUP>H~~-NMR (80 MHz): 0.9(t, 3H, (CH2)16CH3); 1.30(br. s, ca.32H, (CH2)l6CH3); 2.06 (s, 3H, COCH3); 3.35(s, ca. 9H, N(CH3)3); ca. 3.4.-4.50 (m, ca. l0H, 4-OCH2 and CH2-N(CH3)3); 5.10(m, lH, H-C(2) <<0015>>,		\|NMR Spectra=SUPFONT SIZE=-11/FONT/SUPH-NMR (80 MHz): 0.9(t, 3H, (CH2)16CH3); 1.30(br. s, ca.32H, (CH2)l6CH3); 2.06 (s, 3H, COCH3); 3.35(s, ca. 9H, N(CH3)3); ca. 3.4.-4.50 (m, ca. l0H, 4-OCH2 and CH2-N(CH3)3); 5.10(m, lH, H-C(2) 0015,
	}}		}}

	{{Lipid/Footer}}		{{Lipid/Footer}}

Editor: LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001:01 moved to LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001

2010-01-20T01:39:05Z

LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001:01 moved to LBGPCkcp:18000SC01:YS2CA0001:YB2PHb001

← Older revision		Revision as of 10:39, 20 January 2010
(No difference)

Editor at 13:00, 26 July 2009

2009-07-26T13:00:00Z

← Older revision		Revision as of 22:00, 26 July 2009
Line 1:		Line 1:
			{{Lipid/Header}}

	{{Metabolite		{{Metabolite
	\|LipidBank=PPA0020		\|LipidBank=PPA0020
Line 8:		Line 10:
	\|NMR Spectra=<SUP><FONT SIZE=-1>1</FONT></SUP>H-NMR (80 MHz): 0.9(t, 3H, (CH2)16CH3); 1.30(br. s, ca.32H, (CH2)l6CH3); 2.06 (s, 3H, COCH3); 3.35(s, ca. 9H, N(CH3)3); ca. 3.4.-4.50 (m, ca. l0H, 4-OCH2 and CH2-N(CH3)3); 5.10(m, lH, H-C(2) <<0015>>,		\|NMR Spectra=<SUP><FONT SIZE=-1>1</FONT></SUP>H-NMR (80 MHz): 0.9(t, 3H, (CH2)16CH3); 1.30(br. s, ca.32H, (CH2)l6CH3); 2.06 (s, 3H, COCH3); 3.35(s, ca. 9H, N(CH3)3); ca. 3.4.-4.50 (m, ca. l0H, 4-OCH2 and CH2-N(CH3)3); 5.10(m, lH, H-C(2) <<0015>>,
	}}		}}

			{{Lipid/Footer}}

Editor at 12:00, 8 July 2009

2009-07-08T12:00:00Z

New page

{{Metabolite
|LipidBank=PPA0020
|SysName=1-O-Octadecyl-2-O-acetyl-sn-glyceryl-3-phosphocholine
|Common Name=&&Platelet Activating Factor&&1-O-Octadecyl-2-O-acetyl-sn-glyceryl-3-phosphocholine&&
|Melting Point=260° <<0015>>
|Reflactive=[a]D= -0.48° (c=5, CHCl3/CH3OH 1/1) <<0015>>
|IR Spectra=3460 (H2O); 1746 (Ester-Carbonyl); 1256 (Ester and P=O); 1100 (Ether); 1069(P-O). <<0015>>
|NMR Spectra=1H-NMR (80 MHz): 0.9(t, 3H, (CH2)16CH3); 1.30(br. s, ca.32H, (CH2)l6CH3); 2.06 (s, 3H, COCH3); 3.35(s, ca. 9H, N(CH3)3); ca. 3.4.-4.50 (m, ca. l0H, 4-OCH2 and CH2-N(CH3)3); 5.10(m, lH, H-C(2) <<0015>>,
}}